These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 7903060

  • 1. Synthesis of a [11C]methoxy derivative of alpha-dihydrotetrabenazine: a radioligand for studying the vesicular monoamine transporter.
    DaSilva JN, Kilbourn MR, Mangner TJ.
    Appl Radiat Isot; 1993 Dec; 44(12):1487-9. PubMed ID: 7903060
    [Abstract] [Full Text] [Related]

  • 2. In vivo imaging of the brain vesicular monoamine transporter.
    Vander Borght TM, Kilbourn MR, Koeppe RA, DaSilva JN, Carey JE, Kuhl DE, Frey KA.
    J Nucl Med; 1995 Dec; 36(12):2252-60. PubMed ID: 8523116
    [Abstract] [Full Text] [Related]

  • 3. Amino- and amido-tetrabenazine derivatives: synthesis and evaluation as potential ligands for the vesicular monoamine transporter.
    Canney DJ, Kung MP, Kung HF.
    Nucl Med Biol; 1995 May; 22(4):527-35. PubMed ID: 7550031
    [Abstract] [Full Text] [Related]

  • 4. Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine.
    Koeppe RA, Frey KA, Kuhl DE, Kilbourn MR.
    J Cereb Blood Flow Metab; 1999 Dec; 19(12):1376-84. PubMed ID: 10598942
    [Abstract] [Full Text] [Related]

  • 5. Binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific.
    Kilbourn M, Lee L, Vander Borght T, Jewett D, Frey K.
    Eur J Pharmacol; 1995 May 24; 278(3):249-52. PubMed ID: 7589162
    [Abstract] [Full Text] [Related]

  • 6. Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography.
    Koeppe RA, Frey KA, Kume A, Albin R, Kilbourn MR, Kuhl DE.
    J Cereb Blood Flow Metab; 1997 Sep 24; 17(9):919-31. PubMed ID: 9307605
    [Abstract] [Full Text] [Related]

  • 7. Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter.
    Koeppe RA, Frey KA, Vander Borght TM, Karlamangla A, Jewett DM, Lee LC, Kilbourn MR, Kuhl DE.
    J Cereb Blood Flow Metab; 1996 Nov 24; 16(6):1288-99. PubMed ID: 8898703
    [Abstract] [Full Text] [Related]

  • 8. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
    Kilbourn MR, Kuszpit K, Sherman P.
    Synapse; 2000 Mar 15; 35(4):250-5. PubMed ID: 10657034
    [Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter.
    Lee LC, Vander Borght T, Sherman PS, Frey KA, Kilbourn MR.
    J Med Chem; 1996 Jan 05; 39(1):191-6. PubMed ID: 8568807
    [Abstract] [Full Text] [Related]

  • 10. Striatal concentrations of vesicular monoamine transporters are identical in MPTP-sensitive (C57BL/6) and -insensitive (CD-1) mouse strains.
    Kilbourn M, Frey K.
    Eur J Pharmacol; 1996 Jun 27; 307(2):227-32. PubMed ID: 8832225
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and biological evaluation of 10-(11) C-dihydrotetrabenazine as a vesicular monoamine transporter 2 radioligand.
    Li X, Chen Z, Tang J, Liu C, Zou P, Huang H, Tan C, Yu H.
    Arch Pharm (Weinheim); 2014 May 27; 347(5):313-9. PubMed ID: 24497196
    [Abstract] [Full Text] [Related]

  • 12. In vivo imaging of vesicular monoamine transporters in human brain using [11C]tetrabenazine and positron emission tomography.
    Kilbourn MR, DaSilva JN, Frey KA, Koeppe RA, Kuhl DE.
    J Neurochem; 1993 Jun 27; 60(6):2315-8. PubMed ID: 8492135
    [Abstract] [Full Text] [Related]

  • 13. Reproducibility studies with 11C-DTBZ, a monoamine vesicular transporter inhibitor in healthy human subjects.
    Chan GL, Holden JE, Stoessl AJ, Samii A, Doudet DJ, Dobko T, Morrison KS, Adam M, Schulzer M, Calne DB, Ruth TJ.
    J Nucl Med; 1999 Feb 27; 40(2):283-9. PubMed ID: 10025836
    [Abstract] [Full Text] [Related]

  • 14. Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters.
    Kilbourn MR, Frey KA, Vander Borght T, Sherman PS.
    Nucl Med Biol; 1996 May 27; 23(4):467-71. PubMed ID: 8832701
    [Abstract] [Full Text] [Related]

  • 15. A Novel Potential Positron Emission Tomography Imaging Agent for Vesicular Monoamine Transporter Type 2.
    Huang ZR, Tsai CL, Huang YY, Shiue CY, Tzen KY, Yen RF, Hsin LW.
    PLoS One; 2016 May 27; 11(9):e0161295. PubMed ID: 27612194
    [Abstract] [Full Text] [Related]

  • 16. In vivo measurement of the vesicular monoamine transporter in schizophrenia.
    Taylor SF, Koeppe RA, Tandon R, Zubieta JK, Frey KA.
    Neuropsychopharmacology; 2000 Dec 27; 23(6):667-75. PubMed ID: 11063922
    [Abstract] [Full Text] [Related]

  • 17. [Quick and simple synthesis of (11)C-(+)-alpha-dihydrotetrabenazine to be used as a PET radioligand of vesicular monoamine transporters].
    Quincoces G, Collantes M, Catalán R, Ecay M, Prieto E, Martino E, Blesa FJ, Alvarez-Erviti L, Areses P, Arbizu J, Obeso JA, Martí-Climent JM, Richter JA, Peñuelas I.
    Rev Esp Med Nucl; 2008 Dec 27; 27(1):13-21. PubMed ID: 18208777
    [Abstract] [Full Text] [Related]

  • 18. In vivo measures of dopaminergic radioligands in the rat brain: equilibrium infusion studies.
    Kilbourn MR, Sherman PS, Kuszpit K.
    Synapse; 2002 Mar 01; 43(3):188-94. PubMed ID: 11793424
    [Abstract] [Full Text] [Related]

  • 19. Decreased striatal monoaminergic terminals in severe chronic alcoholism demonstrated with (+)[11C]dihydrotetrabenazine and positron emission tomography.
    Gilman S, Koeppe RA, Adams KM, Junck L, Kluin KJ, Johnson-Greene D, Martorello S, Heumann M, Bandekar R.
    Ann Neurol; 1998 Sep 01; 44(3):326-33. PubMed ID: 9749598
    [Abstract] [Full Text] [Related]

  • 20. In vivo binding of (+)-alpha-[3H]dihydrotetrabenazine to the vesicular monoamine transporter of rat brain: bolus vs. equilibrium studies.
    Kilbourn M, Sherman P.
    Eur J Pharmacol; 1997 Jul 23; 331(2-3):161-8. PubMed ID: 9274975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.